# A Comparative Study of Mefloquine and S-P as Prophylaxis Against Malaria in Pregnant HIV + Patients

> **NCT02524444** · PHASE1 · COMPLETED · sponsor: **ORIYOMI OMOTOYOSI AKINYOTU** · enrollment: 142 (actual)

## Conditions studied

- Malaria in Pregnant HIV + Patients

## Interventions

- **DRUG:** Mefloquine
- **DRUG:** Sulphadoxine-Pyrimethamine

## Key facts

- **NCT ID:** NCT02524444
- **Lead sponsor:** ORIYOMI OMOTOYOSI AKINYOTU
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09
- **Primary completion:** 2016-08
- **Final completion:** 2016-08
- **Target enrollment:** 142 (ACTUAL)
- **Last updated:** 2017-12-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02524444

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02524444, "A Comparative Study of Mefloquine and S-P as Prophylaxis Against Malaria in Pregnant HIV + Patients". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT02524444. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*